Cepheid Stock

Stocks

30/04/12

15/02/17	Cepheid : Announces FDA Clearance Of Xpert® Xpress Flu And Xpert Xpress Flu/RSV	PU
05/11/16	Cepheid : Danaher Completes Acquisition Of Cepheid	PR
27/10/16	Cepheid : 30 Minute Or Less Molecular Flu/RSV Test Now Available Outside The US	PR
24/10/16	Cepheid : Announces Receipt of Required Regulatory Clearances in Proposed Acquisition by Danaher Corporation	PR
06/10/16	Cepheid : New Bladder Cancer Test Could Reduce Number Of Invasive Procedures Required For Recurrence Monitoring	PR

06/09/16	Danaher : renforce dans les diagnostics avec Cepheid
06/09/16	Danaher : acquiert le spécialiste des diagnostics Cepheid

Manager	Title	Age	Since
Charles Mwangi DFI	Director of Finance/CFO	59	01/07/2023
Anupama Mokkapati COO	Chief Operating Officer	-	01/11/2021
Laurent Bellon COO	Chief Operating Officer	-	01/08/2018

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CEPHEID	-.--%	+0.36%	-	-	0
THERMO FISHER SCIENTIFIC, INC.	+1.19%	+0.82%	+22.92%	+60.64%	256B
DANAHER CORPORATION	-0.42%	+3.46%	+4.97%	+23.48%	163B
INTUITIVE SURGICAL, INC.	-1.27%	+1.80%	-19.11%	+72.17%	155B
BOSTON SCIENTIFIC CORPORATION	-1.14%	-1.14%	-56.01%	-9.01%	65.3B
SIEMENS HEALTHINEERS AG	-0.17%	+1.04%	-15.38%	-8.70%	51.93B
EDWARDS LIFESCIENCES CORPORATION	+0.29%	+2.87%	+12.37%	+47.17%	52.35B
VEEVA SYSTEMS INC.	-1.48%	-1.63%	+6.01%	+65.40%	50.75B
AGILENT TECHNOLOGIES, INC.	+0.87%	+2.59%	+21.08%	+72.71%	50.04B
WATERS CORPORATION	+2.76%	+5.81%	+33.21%	+91.43%	46.03B
Average	+0.08%	+1.74%	+1.12%	+46.14%	98.94B
Weighted average by Cap.	+0.09%	+1.68%	+3.16%	+48.43%